| RET, ROS1 and ALK fusions in lung cancer K Takeuchi, M Soda, Y Togashi, R Suzuki, S Sakata, S Hatano, R Asaka, ... Nature medicine 18 (3), 378-381, 2012 | 1572 | 2012 |
| KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer K Takeuchi, YL Choi, Y Togashi, M Soda, S Hatano, K Inamura, S Takada, ... Clinical Cancer Research 15 (9), 3143-3149, 2009 | 889 | 2009 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 717 | 2021 |
| Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts K Takeuchi, YL Choi, M Soda, K Inamura, Y Togashi, S Hatano, ... Clinical Cancer Research 14 (20), 6618-6624, 2008 | 618 | 2008 |
| EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers K Inamura, K Takeuchi, Y Togashi, K Nomura, H Ninomiya, M Okui, ... Journal of thoracic oncology 3 (1), 13-17, 2008 | 585 | 2008 |
| Identification of novel isoforms of the EML4-ALK transforming gene in non–small cell lung cancer YL Choi, K Takeuchi, M Soda, K Inamura, Y Togashi, S Hatano, ... Cancer research 68 (13), 4971-4976, 2008 | 571 | 2008 |
| EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset K Inamura, K Takeuchi, Y Togashi, S Hatano, H Ninomiya, N Motoi, ... Modern Pathology 22 (4), 508-515, 2009 | 551 | 2009 |
| KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only Y Togashi, M Soda, S Sakata, E Sugawara, S Hatano, R Asaka, ... PloS one 7 (2), e31323, 2012 | 307 | 2012 |
| Identification of anaplastic lymphoma kinase fusions in renal cancer: Large‐scale immunohistochemical screening by the intercalated antibody‐enhanced polymer method E Sugawara, Y Togashi, N Kuroda, S Sakata, S Hatano, R Asaka, ... Cancer 118 (18), 4427-4436, 2012 | 151 | 2012 |
| Frequent BCOR aberrations in extranodal NK/T‐Cell lymphoma, nasal type A Dobashi, N Tsuyama, R Asaka, Y Togashi, K Ueda, S Sakata, S Baba, ... Genes, Chromosomes and Cancer 55 (5), 460-471, 2016 | 123 | 2016 |
| Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma K Takeuchi, M Soda, Y Togashi, Y Ota, Y Sekiguchi, S Hatano, R Asaka, ... Haematologica 96 (3), 464, 2011 | 117 | 2011 |
| Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1–ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification K Takeuchi, M Soda, Y Togashi, E Sugawara, S Hatano, R Asaka, ... Clinical Cancer Research 17 (10), 3341-3348, 2011 | 112 | 2011 |
| let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis K Inamura, Y Togashi, K Nomura, H Ninomiya, M Hiramatsu, Y Satoh, ... Lung cancer 58 (3), 392-396, 2007 | 107 | 2007 |
| MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts Y Togashi, A Dobashi, S Sakata, Y Sato, S Baba, A Seto, H Mitani, ... Modern Pathology 31 (6), 934-946, 2018 | 79 | 2018 |
| Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t (6; 11) translocation K Inamura, M Fujiwara, Y Togashi, K Nomura, H Mukai, Y Fujii, ... The American journal of surgical pathology 36 (1), 35-42, 2012 | 78 | 2012 |
| Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene H Kusano, Y Togashi, J Akiba, F Moriya, K Baba, N Matsuzaki, Y Yuba, ... The American journal of surgical pathology 40 (6), 761-769, 2016 | 76 | 2016 |
| Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study) K Takeuchi, Y Togashi, Y Kamihara, T Fukuyama, H Yoshioka, A Inoue, ... Annals of Oncology 27 (1), 185-192, 2016 | 60 | 2016 |
| DOCK2 is involved in the host genetics and biology of severe COVID-19 H Namkoong, R Edahiro, T Takano, H Nishihara, Y Shirai, K Sonehara, ... Nature 609 (7928), 754-760, 2022 | 53 | 2022 |
| ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern K Sakamoto, H Nakasone, Y Togashi, S Sakata, N Tsuyama, S Baba, ... International journal of hematology 103, 399-408, 2016 | 37 | 2016 |
| HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell … K Inamura, Y Togashi, H Ninomiya, T Shimoji, T Noda, Y Ishikawa Anticancer research 28 (4B), 2121-2127, 2008 | 26 | 2008 |
Kengo TakeuchiCancer Institute, Japanese Foundation for Cancer Research確認したメール アドレス: umin.net
